CA1338377C - Composition pharmaceutique stabilisee et sa preparation - Google Patents

Composition pharmaceutique stabilisee et sa preparation

Info

Publication number
CA1338377C
CA1338377C CA000616723A CA616723A CA1338377C CA 1338377 C CA1338377 C CA 1338377C CA 000616723 A CA000616723 A CA 000616723A CA 616723 A CA616723 A CA 616723A CA 1338377 C CA1338377 C CA 1338377C
Authority
CA
Canada
Prior art keywords
composition
compound
basic inorganic
sodium
benzimidazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000616723A
Other languages
English (en)
Inventor
Tadashi Makino
Tetsuro Tabata
Shin-Ichiro Hirai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27167671&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA1338377(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CA000529605A external-priority patent/CA1327010C/fr
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of CA1338377C publication Critical patent/CA1338377C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000616723A 1986-02-13 1993-09-14 Composition pharmaceutique stabilisee et sa preparation Expired - Lifetime CA1338377C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2956786 1986-02-13
JP29567/1986 1986-02-13
JP38059/1986 1986-02-21
JP3805986 1986-02-21
CA000529605A CA1327010C (fr) 1986-02-13 1987-02-12 Compositions pharmaceutiques contenant un compose anti-ulcereux de type benzimidazole et sa production

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA000529605A Division CA1327010C (fr) 1986-02-13 1987-02-12 Compositions pharmaceutiques contenant un compose anti-ulcereux de type benzimidazole et sa production

Publications (1)

Publication Number Publication Date
CA1338377C true CA1338377C (fr) 1996-06-11

Family

ID=27167671

Family Applications (2)

Application Number Title Priority Date Filing Date
CA000616724A Expired - Lifetime CA1338399C (fr) 1986-02-13 1993-09-14 Composition pharmaceutique stabilisee et sa preparation
CA000616723A Expired - Lifetime CA1338377C (fr) 1986-02-13 1993-09-14 Composition pharmaceutique stabilisee et sa preparation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA000616724A Expired - Lifetime CA1338399C (fr) 1986-02-13 1993-09-14 Composition pharmaceutique stabilisee et sa preparation

Country Status (1)

Country Link
CA (2) CA1338399C (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077541A (en) * 1997-11-14 2000-06-20 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077541A (en) * 1997-11-14 2000-06-20 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6780435B2 (en) 1997-11-14 2004-08-24 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6855336B2 (en) 1998-08-28 2005-02-15 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation

Also Published As

Publication number Publication date
CA1338399C (fr) 1996-06-18

Similar Documents

Publication Publication Date Title
US5433959A (en) Stabilized pharmaceutical composition
US5045321A (en) Stabilized pharmaceutical composition and its production
US6749864B2 (en) Stabilized pharmaceutical composition
JPH0338247B2 (fr)
EP0208452B1 (fr) Dérivés de pyridine, leur préparation et utilisation
KR101457463B1 (ko) 퀴놀린 화합물을 포함하는 신규 조성물
ES2373864T3 (es) Composición estabilizada que contiene un compuesto de tipo bencimidazol.
BG65255B1 (bg) Нова сол на пантопразол
JP2762998B2 (ja) 医薬固形組成物用安定化剤および安定化方法
CA1338377C (fr) Composition pharmaceutique stabilisee et sa preparation
JPH0825905B2 (ja) 医薬固形組成物用安定化剤および安定化方法
JPH04502460A (ja) 胃酸抑制効果を有する化合物およびその製法
KR950007211B1 (ko) 안전화된 약제 조성물 및 항궤양 약제 조성물의 안정화 방법
AU641465B2 (en) 2((2-pyridinyl)methyl) sulfinyl)-1H-Benzimidazole derivatives
HU196997B (en) Process for producing pyridine derivatives and pharmaceuticals comprising these compounds as active ingredient